Literature DB >> 35846252

Histo-Molecular Profile of Breast Cancer in Young Women in Togo.

Toukilnan Djiwa1, Baumaney Koui2, Panakinao Simgban1, Bagassam Mézéwè Sama1, Mayi Bombonne1, Brahima Doukouré2, Tchin Darré1.   

Abstract

Introduction: The frequency of breast cancer in young women, corresponding to women under 40 years of age; varies from 5% to 7% in developed countries. The objective of this study was to contribute to the improvement of the management of breast cancer in young women in Togo, by establishing the molecular classification of these cancers. Methodology: This was a retrospective descriptive and analytical study from January 2010 to December 2020.
Results: About 35 cases of breast cancer were identified in women under 40 years of age. The average age was 35.4 ± 3.5 years. The right breast was affected in 18 cases (51.43%). Histologically, 30 cases (85.72%) were invasive carcinoma of no special type (NST), 2 cases (5.71%) were invasive lobular carcinoma and micro-papillary carcinoma respectively, and 1 case (2.86%) was tubular carcinoma. There were 6 cases (17.1%) of grade I, 25 cases (71.4%) of grade II, and 4 cases (11.4%) of grade III. Molecularly, there were 20 cases (57.1%) of triple-negative subtype, 6 cases (17.1%) of Luminal B subtype, 05 cases (14.3%) of HER2-enriched subtype and 4 cases (11.4%) of Luminal A subtype.
Conclusion: Breast cancers of young Togolese women express very weakly hormone receptors, with a predominance of a triple negative subtype.
© The Author(s) 2022.

Entities:  

Keywords:  Cancer; Togo; breast; immunohistochemistry; young woman

Year:  2022        PMID: 35846252      PMCID: PMC9280847          DOI: 10.1177/2632010X221112452

Source DB:  PubMed          Journal:  Clin Pathol        ISSN: 2632-010X


  28 in total

1.  First international consensus guidelines for breast cancer in young women (BCY1).

Authors:  Ann H Partridge; Olivia Pagani; Omalkhair Abulkhair; Stefan Aebi; Frédéric Amant; Hatem A Azim; Alberto Costa; Suzette Delaloge; Gloria Freilich; Oreste Davide Gentilini; Nadia Harbeck; Catherine M Kelly; Sibylle Loibl; Dror Meirow; Fedro Peccatori; Bella Kaufmann; Fatima Cardoso
Journal:  Breast       Date:  2014-04-24       Impact factor: 4.380

2.  Breast cancer in young women aged 35 and under: Patterns of care and outcome.

Authors:  Maria Passhak; Shlomit Strulov Shachar; Gil Bar-Sela; Georgeta Fried
Journal:  Breast J       Date:  2017-11-15       Impact factor: 2.431

Review 3.  Breast cancer in adolescents and young adults.

Authors:  Rebecca H Johnson; Carey K Anders; Jennifer K Litton; Kathryn J Ruddy; Archie Bleyer
Journal:  Pediatr Blood Cancer       Date:  2018-08-28       Impact factor: 3.167

4.  Factors influencing the effect of age on prognosis in breast cancer: population based study.

Authors:  N Kroman; M B Jensen; J Wohlfahrt; H T Mouridsen; P K Andersen; M Melbye
Journal:  BMJ       Date:  2000-02-19

Review 5.  Breast cancer under age 40: a different approach.

Authors:  D Ribnikar; J M Ribeiro; D Pinto; B Sousa; A C Pinto; E Gomes; E C Moser; M J Cardoso; F Cardoso
Journal:  Curr Treat Options Oncol       Date:  2015-04

6.  [Breast cancer in young patient in Morocco].

Authors:  K Znati; S Bennis; F Abbass; Y Akasbi; L Chbani; H Elfatemi; T Harmouch; A Amarti
Journal:  Gynecol Obstet Fertil       Date:  2012-04-20

7.  Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.

Authors:  Carey K Anders; David S Hsu; Gloria Broadwater; Chaitanya R Acharya; John A Foekens; Yi Zhang; Yixin Wang; P Kelly Marcom; Jeffrey R Marks; Phillip G Febbo; Joseph R Nevins; Anil Potti; Kimberly L Blackwell
Journal:  J Clin Oncol       Date:  2008-07-10       Impact factor: 44.544

8.  The Impact of Young Age for Prognosis by Subtype in Women with Early Breast Cancer.

Authors:  Weibin Lian; Fangmeng Fu; Yuxiang Lin; Minjun Lu; Boyang Chen; Peidong Yang; Bangwei Zeng; Meng Huang; Chuan Wang
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

9.  BREAST CANCER IN YOUNG WOMEN: PATHOLOGIC AND IMMUNOHISTOCHEMICAL FEATURES.

Authors:  Ivan Erić; Anamarija Petek Erić; Jozo Kristek; Ivan Koprivčić; Marko Babić
Journal:  Acta Clin Croat       Date:  2018-09       Impact factor: 0.780

10.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; David G Hicks; Mitch Dowsett; Lisa M McShane; Kimberly H Allison; Donald C Allred; John M S Bartlett; Michael Bilous; Patrick Fitzgibbons; Wedad Hanna; Robert B Jenkins; Pamela B Mangu; Soonmyung Paik; Edith A Perez; Michael F Press; Patricia A Spears; Gail H Vance; Giuseppe Viale; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2013-10-07       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.